Page 1054 - medicina-integrativa_compress

CAPÍTULO 104 PRESCRIPCIÓN DE PROBIÓTICOS 1083

133. Naidu AS, Bidlack WR, Clemens RA: Probiotic spectra of lactic
acid bacteria. Crit Rev Food Sci Nutr 39:13, 1999. BIBLIOGRAFÍA RECOMENDADA
134. Salminen S, von Wright A, Morelli L, et al: Demonstration of safety
of probiotics—a review. Int J Food Microbiol 44:93, 1998. Bengmark S: Ecological control of the gastrointestinal tract: The role of
135. Wagner RD, Warner T, Roberts L, et al: Colonization of probiotic flora. Gut 42:2, 1998.
congenitally immunodeficient mice with probiotic bacteria. Infect Chen CC, Walker WA: Probiotics and prebiotics: Role in clinical disease
Immun 65:3345-3351, 1997. states. Adv Pediatr 52:77, 2005.
136. Ishibashi N, Yamazaki S: Probiotics and safety. Am J Clin Nutr Collins MD, Gibson GR: Probiotics, prebiotics, and synbiotics:
73(Suppl):465S, 2001. Approaches for modulating the microbial ecology of the gut. Am J
137. Saavedra JM, Abi-Hanna A, Moore N, Yolken RH: Long-term Clin Nutr 69(Suppl):1052S, 1999.
consumption of infant formulas containing live probiotic bacteria: de Roos NM, Katan MB: Effects of probiotic bacteria on diarrhea, lipid
Tolerance and safety. Am J Clin Nutr 79:261, 2004. metabolism, and carcinogenesis: A review of papers published
138. Salminen MK, Tynkkynen S, Rautelin H, et al: Lactobacillus between 1988 and 1998. Am J Clin Nutr 71:405, 2000.
bacteremia during a rapid increase in probiotic use of Lactobacillus Doron S, Snydman DR, Gorbach SL: Lactobacillus GG: Bacteriology
rhamnosus GG in Finland. Clin Infect Dis 35:1155, 2002. and clinical applications. Gastroenterol Clin North Am 34:483,
139. Notario R, Leardini N, Borda N, et al: Hepatic abscess and bacteremia 2005.
due to Lactobacillus rhamnosus. Rev Argent Microbiol 35:100, 2003. Jenkins B, Holsten S, Bengmark S, et al: Probiotics: A practical review
140. Rautio M, Jousimies-Somer H, Kauma H, et al: Liver abscess due to of their role in specific clinical scenarios. Nutr Clin Pract 20:262,
a Lactobacillus rhamnosus strain indistinguishable from 2005.
L. rhamnosus strain GG. Clin Infect Dis 28:1159, 1999. Orrhage K, Nord CE: Bifidobacteria and lactobacilli in human health.
141. Young RJ, Vanderhoof JA: Two cases of Lactobacillus bacteremia Drugs Exp Clin Res 26:95, 2000.
during probiotic treatment of short gut syndrome. J Pediatr Picard C, Fioramonti J, Francois A, et al: Review article: Bifidobacteria as
Gastroenterol Nutr 39:436, 2004. probiotic agents— physiological effects and clinical benefits. Aliment
142. Pletincx M, Legein J, Vandenplas Y: Fungemia with Saccharomyces Pharmacol Ther 22:495, 2005.
boulardii in a 1-year-old girl with protracted diarrhea. J Pediatr Saavedra JM: Probiotics plus antibiotics: Regulating our bacterial
Gastroenterol Nutr 21:113, 1995. environment. J Pediatr 135:535, 1999.
143. Rijnders BJ, Van Wijngaerden E, Verwaest C, Peetermans WE: Snelling AM: Effects of probiotics on the gastrointestinal tract. Curr Opin
Saccharomyces fungemia complicating Saccharomyces boulardii Infect Dis 18:420, 2005.
treatment in a non-immunocompromised host. Intens Care Med Vanderhoof JA: Probiotics and intestinal inflammatory disorders in
26:825, 2000. infants and children. J Pediatr Gastroenterol Nutr 30:S34, 2000.

© Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.